Artman Technologies

Artman Technologies has developed a state-of-the-art National Transplant Systems, that revolutionized the Organ, Tissue, and Cell procurement and transplantation procesess. This integrated platform streamlines the entire transplantation process, from donor identification and organ allocation to post-transplant monitoring, ensuring efficiency, transparency, and equity in organ distribution.

Widely adopted by leading organizations such as **NHS Blood and Transplant (NHSBT)** in the UK, the **Slovak National Transplant Organization (NTO)*, *Slovenia Transplant (ST)*, *Saudi Center for Organ Transplantation (SCOT)**, Egypt & Kyrgyzstan OPOs and others, the system incorporates advanced features like **virtual crossmatch, HLA matching*, *kidney and liver pairing programs*, also *tissues and cells allocation* for both *living and cadaveric** donors. Its robust algorithms ensure precise donor-recipient matching based on medical urgency, compatibility, and geographic proximity, while real-time data analytics and secure communication protocols facilitate seamless coordination among healthcare providers, transplant centers, and organ procurement organizations (OPOs).

Artman Technologies has also played a pivotal role in European Union projects, including **DonorAction*, * Eurodonor* , *Eurocet* , *Eurocet128** deployed for the European Commission. These initiatives have further advanced the standardization and interoperability of transplant systems across Europe, enhancing cross-border collaboration and improving access to life-saving transplants.

The platform includes tools for tracking organ viability, optimizing logistics, and ensuring regulatory compliance, meeting both national and international standards. By integrating tissue and cell procurement alongside with solid organ transplantation, Artman Technologies offers a holistic solution that addresses the diverse needs of modern transplant systems.